Skip to main content
VCbacked
Log inGet Started

TauC3 Biologics Limited

Holborn, United Kingdom

biopharmaceutical company focused on the development of innovative immunotherapies for the treatment of tauopathies.

$2.5M raised
Dec 2025
Seed
BiotechnologyPharmaceutical

Top Investors

Alzheimer's AssociationRainwater Charitable Foundation

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about TauC3 Biologics Limited

How much funding has TauC3 Biologics Limited raised?
TauC3 Biologics Limited has raised $2.5M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
Who are TauC3 Biologics Limited's investors?
TauC3 Biologics Limited's investors include Alzheimer's Association, Rainwater Charitable Foundation.
Where is TauC3 Biologics Limited headquartered?
TauC3 Biologics Limited is headquartered in Holborn, United Kingdom.
What does TauC3 Biologics Limited do?
biopharmaceutical company focused on the development of innovative immunotherapies for the treatment of tauopathies.
What stage is TauC3 Biologics Limited at?
TauC3 Biologics Limited is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"TauC3 Biologics Limited — Funding & Investors." VCBacked, December 9, 2025, https://www.vcbacked.co/company/tauc3-biologics-limited. Accessed June 17, 2026.
APA
VCBacked. (2025). TauC3 Biologics Limited — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/tauc3-biologics-limited
Wikipedia (cite web)
{{cite web |title=TauC3 Biologics Limited — Funding & Investors |url=https://www.vcbacked.co/company/tauc3-biologics-limited |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong